Sat, Dec 27, 2014, 2:43 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Infinity Pharmaceuticals, Inc. (INFI) Message Board

  • greenshotshut greenshotshut Jun 14, 2013 3:12 PM Flag

    Infinity Pharmaceuticals weakness an overreaction, says Stifelject

    After meeting with Infinity's management, Stifel views weakness in the shares following ASCO data as an overreaction. The firm thinks that the ASCO data reaffirmed that IPI-145 is an active drug in iNHL and CLL, and it views the drug as competitive with other hematological malignancy drugs that are being developed. The firm keeps a Buy rating on the stock.

    Sentiment: Strong Buy

16.70+0.05(+0.30%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Tesla Motors, Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST